Human lung organoid are three-dimensional, self-organizing tissue models derived from primary human lung epithelial progenitors or adult stem cells isolated from patient biopsy or resected lung tissue. These organoids faithfully recapitulate lung-specific structures, including airway-like epithelium and alveolar-like compartments containing AT1 and AT2 cells, supported by stromal and endothelial components. They express lineage markers such as NKX2.1, SPC, and AQP5, and maintain genomic stability throughout culture. Quality control ensures organoids are free from mycoplasma, bacteria, and fungi/yeast, with validated identity and functional performance. Human lung organoids serve as robust platforms for studying pulmonary development, modeling respiratory diseases such as fibrosis, infection, and cancer, and enabling drug discovery, personalized medicine, and regenerative therapies.
Embedded 3D Culture
All test negative for mycoplasma, bacteria, yeast, and fungi.
For research use only. Tissue-derived organoids are widely used in drug screening, disease modeling, mechanism research, personalized medicine, and regenerative medicine. By simulating authentic disease states, these organoids provide an ideal platform to assess patient responses to new drugs and assist in the design of personalized treatment plans. Additionally, they drive the development of new therapeutic approaches, particularly in cancer research and organ regeneration, offering precise experimental tools that greatly enhance the advancement of precision medicine.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.